The combination of flucytosine and amphotericin B is first choice treatment for active cryptococcosis. Because of innate or acquired resistance of Cryptococcus neoformans to flucytosine, in vitro testing is mandatory. Yeast nitrogen base (YNB) at pH 7.0 is the recommended medium for the broth microdilution test (NCCLS M27-A) and for the E-test. In order to verify if minimum inhibitory concentrations (MICs) were able to predict treatment outcome, the susceptibility of 24 isolates from 21 patients treated with flucytosine alone or in combination was tested by the broth microdilution, agar dilution and E-test using YNB either at pH 7.0 or at pH 5.4. Only those MICs obtained on YNB pH 5.4 proved to correlate with treatment outcome. The present study suggests that in vitro susceptibility to flucytosine of C. neoformans isolates should be evaluated on YNB pH 5.4 and the test should be standardized accordingly.

Flucytosine and cryptococcosis : which in vitro test is the best predictor of outcome? / M.A. Savoldelli, M.C. Esposto, M. Cogliati, A.M. Tortorano. - In: JOURNAL OF CHEMOTHERAPY. - ISSN 1120-009X. - 15:2(2003 Apr), pp. 124-128.

Flucytosine and cryptococcosis : which in vitro test is the best predictor of outcome?

M.A. Savoldelli;M.C. Esposto;M. Cogliati;A.M. Tortorano
2003-04

Abstract

The combination of flucytosine and amphotericin B is first choice treatment for active cryptococcosis. Because of innate or acquired resistance of Cryptococcus neoformans to flucytosine, in vitro testing is mandatory. Yeast nitrogen base (YNB) at pH 7.0 is the recommended medium for the broth microdilution test (NCCLS M27-A) and for the E-test. In order to verify if minimum inhibitory concentrations (MICs) were able to predict treatment outcome, the susceptibility of 24 isolates from 21 patients treated with flucytosine alone or in combination was tested by the broth microdilution, agar dilution and E-test using YNB either at pH 7.0 or at pH 5.4. Only those MICs obtained on YNB pH 5.4 proved to correlate with treatment outcome. The present study suggests that in vitro susceptibility to flucytosine of C. neoformans isolates should be evaluated on YNB pH 5.4 and the test should be standardized accordingly.
Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Culture Media; Drug Therapy, Combination; Female; Flucytosine; Humans; Hydrogen-Ion Concentration; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Treatment Outcome
Settore MED/42 - Igiene Generale e Applicata
JOURNAL OF CHEMOTHERAPY
Article (author)
File in questo prodotto:
File Dimensione Formato  
Flucytosine and Cryptococcosis Which In Vitro Test Is the Best Predictor of Outcome.pdf

non disponibili

278.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/532441
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 16
social impact